Spruce Biosciences, Inc. (SPRB) vs Voyager Therapeutics, Inc. (VYGR)

Spruce Biosciences, Inc. and Voyager Therapeutics, Inc. are both Biotechnology companies. Spruce Biosciences, Inc. and Voyager Therapeutics, Inc. are of similar size ($126.9M and $119.2M). Voyager Therapeutics, Inc. grew revenue faster over the last twelve months: −19.1% against −51.3%. Spruce Biosciences, Inc. has the higher net margin (0.00% vs −312.6%) and the higher return on invested capital (0.00% vs −192.6%). Across the 16 metrics below, Spruce Biosciences, Inc. leads on 8 and Voyager Therapeutics, Inc. on 8.

Valuation

Metric SPRB VYGR Biotechnology median
P/E n/m n/m 8.50
P/S 19.63 3.34 9.71
P/B 1.15 0.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.01 0.64
EV/Sales 1.46 (0.04) 9.21
Earnings yield (100.33%) (95.26%) (33.15%)
Free cash flow yield (44.38%) (105.54%) (25.50%)

Profitability

Metric SPRB VYGR Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (340.08%) 0.00%
Net margin 0.00% (312.63%) 0.00%
Free cash flow margin 0.00% (352.36%) 0.00%
Return on equity (105.98%) (54.09%) (56.36%)
Return on assets (82.38%) (41.45%) (48.04%)
Return on invested capital 0.00% (192.55%) 0.00%

Growth

Metric SPRB VYGR Biotechnology median
Revenue growth (TTM) (51.32%) (19.07%) 6.02%
EPS growth (last fiscal year) 47.59% (80.53%) 30.26%
Revenue growth, 5-year CAGR — (25.09%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SPRB VYGR Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 9.23 7.51 4.72
Net debt to EBITDA 1.34 1.50 0.96

Dividend

Metric SPRB VYGR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SPRB VYGR Biotechnology median
Market cap 119.19m 126.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack